A Follow-Up Report of an Infant Born to a Mother Receiving Tamoxifen

Tamoxifen, an estrogen receptor antagonist, is contraindicated in pregnant women due to its teratogenic activity. In the present study, we report the case of an infant whose mother received tamoxifen for breast cancer while unaware of the pregnancy. The infant, born at 29 weeks and 6 days of gestati...

Descripción completa

Detalles Bibliográficos
Autores principales: Okada, Yuki, Hitaka, Daisuke, Kido, Takahiro, Kanai, Yu, Konishi, Kumi, Doki, Kosuke, Katayama, Nobuko, Homma, Masato, Miyazono, Yayoi, Takada, Hidetoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399775/
https://www.ncbi.nlm.nih.gov/pubmed/32774971
http://dx.doi.org/10.1155/2020/2056756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399775/
https://www.ncbi.nlm.nih.gov/pubmed/32774971
http://dx.doi.org/10.1155/2020/2056756

Ejemplares similares